| |
|
|
|
|
| ·Adrenocorticotropic
Hormone(ACTH) & Related Peptides |
Product |
CAT# |
Sequence |
ACTH (1-10),
human |
TYA019-010
TYA019-050 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly |
ACTH (1-13),
human |
TYA020-005
TYA020-010 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val |
ACTH (1-16),
human |
TYA021-005
TYA021-010 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys |
ACTH (1-17),
human |
TYA022-005
TYA022-010 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg |
ACTH (1-24),
human |
TYA023-005
TYA023-010 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
ACTH (18-39),
human |
TYA024-005
TYA024-010 |
Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe |
ACTH (4-10),
human |
TYA025-010
TYA025-050 |
Met-Glu-His-Phe-Arg-Trp-Gly |
ACTH (4-11),
human |
TYA026-010
TYA026-050 |
Met-Glu-His-Phe-Arg-Trp-Gly-Lys |
ACTH (6-24),
human |
TYA027-005
TYA027-010 |
His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro |
N-Acetyl,
ACTH (1-17), human |
TYN001-005
TYN001-010 |
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg |
|
|
| ·Adrenomedullin |
Product |
CAT# |
Sequence |
Adrenomedullin
(1-12), human |
TYA033-005
TYA033-010 |
Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg |
Adrenomedullin
(22-52), human |
TYA034-001 |
Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 |
Pro-Adrenomedullin
(153-185), human |
TYP056-001
TYP056-005 |
Ser-Leu-Pro-Glu-Ala-Gly-Pro-Gly-Arg-Thr-Leu-Val-Ser-Ser-Lys-Pro-Gln-Ala-His-Gly-Ala-Pro-Ala-Pro-Pro-Ser-Gly-Ser-Ala-Pro-His-Phe-Leu |
Pro-Adrenomedullin
(N-20), porcine |
TYP057-005
TYP057-010 |
Ala-Arg-Leu-Asp-Val-Ala-Ala-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 |
Pro-Adrenomedullin
N-20, rat |
TYP059-005 |
Ala-Arg-Leu-Asp-Thr-Ser-Ser-Gln-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 |
|
|
|
Product |
CAT# |
Sequence |
Allatostatin
I |
TYA041-010
TYA041-050 |
Ala-Pro-Ser-Gly-Ala-Gln-Arg-Leu-Tyr-Gly-Phe-Gly-Leu-NH2 |
Allatostatin
II |
TYA042-010
TYA042-050 |
Gly-Asp-Gly-Arg-Leu-Tyr-Ala-Phe-Gly-Leu-NH2 |
Allatostatin
III |
TYA043-010
TYA043-050 |
Gly-Gly-Ser-Leu-Tyr-Ser-Phe-Gly-Leu-NH2 |
Allatostatin
IV |
TYA044-010
TYA044-050 |
Asp-Arg-Leu-Tyr-Ser-Phe-Gly-Leu-NH2 |
|
|
| ·β-Amyloids |
Product |
CAT# |
Sequence |
Amyloid 17-42 |
TYA048-001 |
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala |
[Gln11] β-Amyloid
(1-16) |
TYA050-005
TYA050-010 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys |
β-Amyloid
(1-11) |
TYA053-005
TYA053-010 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu |
β-Amyloid
(1-28) |
TYA054-005
TYA054-010 |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
β-Amyloid
(10-20) |
TYA055-005
TYA055-010 |
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe |
β-Amyloid
(12-28) |
TYA056-005
TYA056-010 |
Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
β-Amyloid
(17-40) |
TYA057-005
TYA057-010 |
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val |
β-Amyloid
(22-35) |
TYA058-005
TYA058-010 |
Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met |
β-Amyloid
(25-35) |
TYA059-005
TYA059-010 |
Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met |
β-Amyloid
(35-25) |
TYA062-005
TYA062-010 |
Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly |
β-Amyloid
/ A4 Protein Precursor (APP) (96-110) |
TYA064-005
TYA064-010 |
Ac-Asn-Trp-Cys-Lys-Arg-Gly-Arg-Lys-Gln-Cys-Lys-Thr-His-Pro-His-NH2 |
β-Amyloid
/ A4 Protein
Precursor (APP) (319-335) |
TYA065-005
TYA065-010 |
Ala-Lys-Glu-Arg-Leu-Glu-Ala-Lys-His-Arg-Glu-Arg-Met-Ser-Gln-Val-Met |
β-Amyloid
Precursor
Protein (657-676) |
TYA066-005
TYA066-010 |
His-His-Gly-Val-Val-Glu-Val-Asp-Ala-Ala-Val-Thr-Pro-Glu-Glu-Arg-His-Leu-Ser-Lys |
|
|
| ·Angiotensins |
Product |
CAT# |
Sequence |
Angiogenin
Fragment (108-122) |
TYA069-010 |
Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg |
Angiogenin
Fragment (108-123) |
TYA070-010 |
Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg-Pro |
Angiotensin
I, human |
TYA073-050 |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu |
Apelin-13,
human, bovine |
TYA102-005
TYA102-010 |
Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe |
[Ala-Pro-Gly-(Ile3,Val5)]
Angiotensin II |
TYA085-050 |
Ala-Pro-Gly-Asp-Arg-Ile-Tyr-Val-His-Pro-Phe |
[Asn1,
Val5, Asn9]
Angiotensin I, salmon |
TYA078-050 |
Asn-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu |
[Asn1,Val5]
Angiotensin II |
TYA086-050 |
Asn-Arg-Val-Tyr-Val-His-Pro-Phe |
[Ile7]
Angiotensin III |
TYA090-050 |
Arg-Val-Tyr-Ile-His-Pro-Ile |
[Val4]
Angiotensin III |
TYA091-050 |
Arg-Val-Tyr-Val-His-Pro-Phe |
[Val5]
Angiotensin II, human |
TYA087-050 |
Asp-Arg-Val-Tyr-Val-His-Pro-Phe |
|
|
| ·Atrial
Natriuretic Peptides |
Product |
CAT# |
Sequence |
Anantin |
TYA068-005
TYA068-010 |
Gly-Phe-Ile-Gly-Trp-Gly-Asn-Asp-Ile-Phe-Gly-His-Tyr-Ser-Gly-Asp-Phe |
ANP (1-11),
rat |
TYA096-010 |
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg |
Cardiodilatin
(1-16), human |
TYC025-010
TYC025-050 |
Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys |
Prepro-ANF
(104-116), human |
TYP038-005
TYP038-010 |
Ser-Ser-Asp-Arg-Ser-Ala-Leu-Leu-Lys-Ser-Lys-Leu-Arg |
Prepro-ANF
(104-123), human |
TYP039-005
TYP039-010 |
Ser-Ser-Asp-Arg-Ser-Ala-Leu-Leu-Lys-Ser-Lys-Leu-Arg-Ala-Leu-Leu-Thr-Ala-Pro-Arg |
Prepro-ANF
(26-55), human |
TYP040-005
TYP040-010 |
Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys-Asn-Leu-Leu-Asp-His-Leu-Glu-Glu-Lys-Met-Pro-Leu-Glu-Asp |
|
|
| ·Bag
Cell Peptides |
Product |
CAT# |
Sequence |
| a-Bag Cell Peptide
(1-7) |
TYB002-010 |
Ala-Pro-Arg-Leu-Arg-Phe-Tyr |
| a-Bag Cell Peptide
(1-8) |
TYB003-010 |
Ala-Pro-Arg-Leu-Arg-Phe-Tyr-Ser |
| a-Bag Cell Peptide
(1-9) |
TYB004-010 |
Ala-Pro-Arg-Leu-Arg-Phe-Tyr-Ser-Leu |
| b-Bag Cell Factor |
TYB005-010 |
Arg-Leu-Arg-Phe-His |
| g-Bag Cell Factor |
TYB006-010 |
Arg-Leu-Arg-Phe-Asp |
|
|
| ·Bone
Gla Proteins |
Product |
CAT# |
Sequence |
| Bone Gla Protein
(45-49) |
TYB028-010
TYB028-050 |
Phe-Tyr-Gly-Pro-Val |
| Myelopeptide–2
(MP-2) |
TYM046-005
TYM046-010 |
Leu-Val-Val-Tyr-Pro-Trp |
| Osteocalcin (37-49),
human |
TYO006-010
TYO006-050 |
Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val |
| [Tyr38, Phe42,46]
Bone Gla Protein (38-49), human |
TYB029-010 |
Tyr-Gln-Glu-Ala-Phe-Arg-Arg-Phe-Phe-Gly-Pro-Val |
|
|
| ·Bradykinins |
Product |
CAT# |
Sequence |
Bradykinin |
TYB032-100 |
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
Lys-(Des-Arg9,
Leu8)-Bradykinin |
TYL038-050 |
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu |
[Ile-Ser0]-Bradykinin |
TYB039-050 |
Ile-Ser-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
[Lys0-Ala3]
Bradykinin |
TYB040-050
TYB040-025 |
Lys-Arg-Pro-Ala-Gly-Phe-Ser-Pro-Phe-Arg |
[Lys0] Bradykinin |
TYB042-050
TYB042-250 |
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
[Met-Lys0]
Bradykinin |
TYB043-050
TYB043-250 |
Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
[Tyr0] Bradykinin |
TYB044-050 |
Tyr-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg |
[Tyr5] Bradykinin |
TYB045-050 |
Arg-Pro-Pro-Gly-Tyr-Ser-Pro-Phe-Arg |
[Tyr8] Bradykinin |
TYB046-050 |
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg |
|
|
| ·Calcitonin
Gene Related Peptide |
Product |
CAT# |
Sequence |
Calcitonin
C-terminal
Adjacent Peptide, rat |
TYC009-005
TYC009-010 |
Asp-Met-Ala-Lys-Asp-Leu-Glu-Thr-Asn-His-His-Pro-Tyr-Phe-Gly-Asn |
Calcitonin Gene
Related
Peptide (20-37), human |
TYC011-005
TYC011-010 |
Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 |
Calcitonin Gene
Related
Peptide (8-37), human |
TYC012-005
TYC012-010 |
Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 |
Calcitonin Gene
Related
Peptide (8-37), rat |
TYC013-005
TYC013-010 |
Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 |
| Katacalcin |
TYC003-005
TYC003-010 |
Asp-Met-Ser-Ser-Asp-Leu-Glu-Arg-Asp-His-Arg-Pro-His-Val-Ser-Met-Pro-Gln-Asn-Ala-Asn |
[Tyr0] Calcitonin
Gene
Related Peptide (28-37), rat |
TYC014-005
TYC014-010 |
Tyr-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 |
[Tyr22] Calcitonin
Gene
Related Peptide, (22-37), rat |
TYC015-005
TYC015-010 |
Tyr-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 |
|
|
| ·Cholecystokinins(CCK) |
Product |
CAT# |
Sequence |
| Cholecystokinin
Flanking Peptide, Non sulfated |
TYC051-010 |
Ser-Ala-Glu-Glu-Tyr-Glu-Tyr-Pro-Ser |
| Cholecystokinin,
CCK Octapeptide (26-33), Non-Sulfated form |
TYC049-010
TYC049-050 |
Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 |
| Cholecystokinin,
CCK (27-33) |
TYC048-010
TYC048-050 |
Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 |
| Cholecystokinin,
CCK Tetrapeptide (30-33) |
TYC050-010 |
Trp-Met-Asp-Phe-NH2 |
| N-Acetyl Cholecystokinin,
CCK (26-31), non-sulfated |
TYN002-010
TYN002-050 |
Ac-Asp-Tyr-Met-Gly-Trp-Met-NH2 |
| Prepro CCK fragment
V-9-M |
TYP041-010 |
Val-Pro-Val-Glu-Ala-Val-Asp-Pro-Met |
|
|
| ·Casomorphin |
Product |
CAT# |
Sequence |
b-Casomorphin
(1-6), bovine |
TYC033-010 |
Tyr-Pro-Phe-Pro-Gly-Pro |
| b-Casomorphin(1-7),
bovine |
TYC034-050
TYC034-250 |
Tyr-Pro-Phe-Pro-Gly-Pro-Ile |
| b-Casomorphin,
human |
TYC035-050
TYC035-250 |
Tyr-Pro-Phe-Val-Glu-Pro-Ile |
| [Des-Tyr1] b-Casomorphin,
bovine |
TYC036-010
TYC036-050 |
Pro-Phe-Pro-Gly-Pro-Ile |
| β-Casomorphin (1-5),
amide, bovine |
TYC039-010 |
Tyr-Pro-Phe-Pro-Gly-NH2 |
| β-Casomorphin (1-5),
bovine |
TYC040-010 |
Tyr-Pro-Phe-Pro-Gly |
|
|
| ·Dynorphins |
Product |
CAT# |
Sequence |
Dynorphin
(2-17), amide, porcine |
TYD010-010 |
Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-NH2 |
Dynorphin
A (1-17) |
TYD011-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln |
Dynorphin
A amide, porcine |
TYD012-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-NH2 |
Dynorphin
B (1-9) |
TYD016-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe |
Prodynorphin
(228-240), porcine |
TYP048-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr |
Prodynorphin
(228-256), porcine |
TYP049-005
TYP049-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr-Arg-Ser-Gln-Glu-Asp-Pro-Asn-Ala-Tyr-Tyr-Glu-Glu-Leu-Phe-Asp-Val |
| [Des-Tyr1] Dynorphin
A (1-8) |
TYD015-010 |
Gly-Gly-Phe-Leu-Arg-Arg-Ile |
| [Phe7] Dynorphin
A (1-7), amide, porcine |
TYD013-005
TYD013-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Phe-NH2 |
| [Phe7] Dynorphin
A (1-7), porcine |
TYD014-005
TYD014-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Phe |
|
|
| ·Enkephalins |
Product |
CAT# |
Sequence |
Adrenorphin,
Free Acid |
TYA036-010
TYA036-050 |
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val |
Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Met |
TYA039-010
TYA039-050 |
Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Met |
Leu-Enkephalin,
amide |
TYL015-050 |
Tyr-Gly-Gly-Phe-Leu-NH2 |
Leu-Enkephalin |
TYL016-250 |
Tyr-Gly-Gly-Phe-Leu |
Met-Enkephalin |
TYM022-050 |
Tyr-Gly-Gly-Phe-Met |
Met-Enkephalin,
amide |
TYM023-100 |
Tyr-Gly-Gly-Phe-Met-NH2 |
Preproenkephalin
B (186-204), human |
TYP051-010 |
Ser-Ser-Glu-Val-Ala-Gly-Glu-Gly-Asp-Gly-Asp-Ser-Met-Gly-His-Glu-Asp-Leu-Tyr |
Spinorphin,
bovine |
TYS033-010 |
Leu-Val-Val-Tyr-Pro-Trp-Thr |
[Ala2]
Met-Enkephalin, amide |
TYM024-050 |
Tyr-Ala-Gly-Phe-Met-NH2 |
| [Arg0] Met-Enkephalin |
TYM025-010 TYM026-050 |
Arg-Tyr-Gly-Gly-Phe-Met |
|
|
| ·Endorphin |
Product |
CAT# |
Sequence |
a-Endorphin |
TYE010-010 |
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr |
a-Neo-Endorphin
(1-7) |
TYN006-010
TYN006-050 |
Tyr-Gly-Gly-Phe-Leu-Arg-Lys |
a-Neo-Endorphin
Analog |
TYN007-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Arg-Pro-Lys-NH2 |
a-Neo-Endorphin,
porcine |
TYN008-010 |
Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro-Lys |
Ac,
a-Endorphin |
TYA010-010 |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr |
Ac,
b-Endorphin (1-27), camel, bovine, ovine |
TYA011-010 |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His |
Ac,
g-Endorphin |
TYA012-010 |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-
Leu |
Acetyl,
b-Endorphin (1-26), human |
TYA006-010 |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala |
Acetyl,
b-Endorphin (1-27), human |
TYA007-010 |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr |
b-Endorphin
(1-26), human |
TYE011-010 |
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala |
| b-Endorphin (1-27),
camel, bovine, ovine |
TYE012-010 |
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His |
| b-Endorphin (1-27),
human |
TYE013-010 |
Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr |
| b-Endorphin (1-5)
+ (16-31), human |
TYE014-010 |
Tyr-Gly-Gly-Phe-Met-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu |
|
|
| ·Fibronectin
& Extra Cellular Matrix Related Peptides |
Product |
CAT# |
Sequence |
Fibrinopeptide
A, human |
TYF006-010
TYF006-050 |
Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg |
| Fibronectin Analog |
TYF001-010 |
Gly-Arg-Ala-Asp-Ser-Pro-Lys |
| Fibronectin CS1
Peptide |
TYF011-010
TYF011-050 |
Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr |
| G-R-A-D-S-P |
TYG032-010 |
Gly-Arg-Ala-Asp-Ser-Pro |
| G-R-G-D-N-P |
TYG034-010 |
Gly-Arg-Gly-Asp-Asn-Pro |
| G-R-G-D-S |
TYG035-010
TYG035-050 |
Gly-Arg-Gly-Asp-Ser |
| G-R-G-D-S-P |
TYG036-010 |
Gly-Arg-Gly-Asp-Ser-Pro |
|
|
| ·Glucagon
& Related Peptides |
Product |
CAT# |
Sequence |
Glucagon
(19-29), human |
TYG017-010
TYG017-050 |
Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr |
Glucagon
(22-29), human |
TYG018-010 |
Phe-Val-Gln-Trp-Leu-Met-Asn-Thr |
Glucagon,
human |
TYG016-005
TYG016-010 |
His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr |
Glucagon-like
Peptide I (7-36), amide, human |
TYG021-005
TYG021-010 |
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 |
Valosin
Peptide (VQY), porcine |
TYV003-010 |
Val-Gln-Tyr-Pro-Val-Glu-His-Pro-Asp-Lys-Phe-Leu-Lys-Phe-Gly-Met-Thr-Pro-Ser-Lys-Gly-Val-Leu-Phe-Tyr |
[Des-His1,Glu9]
Glucagon |
TYG019-005
TYG019-010 |
Ser-Gln-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr |
[Des-His1,Glu9]
Glucagon, amide |
TYG020-005
TYG020-010 |
Ser-Gln-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr
–NH2 |
|
|
| ·Growth
Factor Fragments |
Product |
CAT# |
Sequence |
Brain Derived
Acidic Fibroblast Growth Factor (1-11) |
TYB047-010 |
Phe-Asn-Leu-Pro-Leu-Gly-Asn-Tyr-Lys-Lys-Pro |
Brain
Derived Acidic Fibroblast Growth Factor (102-111) |
TYB049-010 |
His-Ala-Glu-Lys-His-Trp-Phe-Val-Gly-Leu |
| Brain Derived Basic
Fibroblast Growth Factor (1-24) |
TYB048-005
TYB048-010 |
Pro-Ala-Leu-Pro-Glu-Asp-Gly-Gly-Ser-Gly-Ala-Phe-Pro-Pro-Gly-His-Phe-Lys-Asp-Pro-Lys-Arg-Leu-Tyr |
| Epidermal Growth
Factor Receptor Peptide (985-996) |
TYE035-010 |
Asp-Val-Val-Asp-Ala-Asp-Glu-Tyr-Leu-Ile-Pro-Gln |
| Insulin-like Growth
Factor I (24-41) |
TYI005-010 |
Tyr-Phe-Asn-Lys-Pro-Thr-Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr |
| Insulin-like Growth
Factor I (30-41) |
TYI006-010 |
Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr |
| Insulin-like Growth
Factor II (69-84) |
TYI009-010 |
Asp-Val-Ser-Thr-Pro-Pro-Thr-Val-Leu-Pro-Asp-Asn-Phe-Pro-Arg-Tyr |
| Insulin-like Growth
[Tyr0] Factor II (33-40) |
TYI010-010 |
Tyr-Ser-Arg-Val-Ser-Arg-Arg-Ser-Arg |
|
|
| ·Leucokinin
& Analogs |
Product |
CAT# |
Sequence |
Leucokinin
I |
TYL007-010 |
Asp-Pro-Ala-Phe-Asn-Ser-Trp-Gly-NH2 |
Leucokinin
II |
TYL008-010 |
Asp-Pro-Gly-Phe-Ser-Ser-Trp-Gly-NH2 |
Leucokinin
III |
TYL009-010 |
Asp-Gln-Gly-Phe-Asn-Ser-Trp-Gly-NH2 |
Leucokinin
IV |
TYL010-010 |
Asp-Ala-Ser-Phe-His-Ser-Trp-Gly-NH2 |
Leucokinin
V |
TYL011-010 |
Gly-Ser-Gly-Phe-Ser-Ser-Trp-Gly-NH2 |
Leucokinin
VII |
TYL012-010 |
Asp-Pro-Ala-Phe-Ser-Ser-Trp-Gly-NH2 |
Leucokinin
VIII |
TYL013-010 |
Gly-Ala-Ser-Phe-Tyr-Ser-Trp-Gly-NH2 |
Leucopyrokinin
(LPK) |
TYL014-010 |
Glp-Thr-Ser-Phe-Thr-Pro-Arg-Leu-NH2 |
|
|
| ·Melanocyte
Stimulating Hormones(MSH) |
Product |
CAT# |
Sequence |
a-MSH, amide |
TYM033-010
TYM033-050 |
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 |
a-MSH,
Free Acid |
TYM037-010 |
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val |
b-MSH,
human |
TYM038-010 |
Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp |
b-MSH,
porcine |
TYM039-010 |
Asp-Glu-Gly-Pro-Tyr-Lys-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp |
g-1-MSH,
amide |
TYM041-010 |
Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2 |
g-MSH |
TYM040-010 |
Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly |
[Des-Ac]
a-MSH, amide |
TYM034-010 |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 |
[Dphe7]
a-MSH, amide |
TYM035-010 |
Ac-Ser-Tyr-Ser-Met-Glu-His-Dphe-Arg-Trp-Gly-Lys-Pro-Val-NH2 |
| [Lys0] g-1-MSH,
amide |
TYM042-010 |
Lys-Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2 |
|
|
| ·Melanoma
Peptides |
Product |
CAT# |
Sequence |
Glu-Glu-Lys-Leu-Ile-Val-Val-Ala-Phe |
TYG023-010 |
Glu-Glu-Lys-Leu-Ile-Val-Val-Ala-Phe |
| Ile-Met-Gln-Val-Pro-Phe-Ser-Val |
TYI001-010 |
Ile-Met-Gln-Val-Pro-Phe-Ser-Val |
| Ile-Thr-Gln-Val-Pro-Phe-Ser-Val |
TYI002-010
TYI002-050 |
Ile-Thr-Gln-Val-Pro-Phe-Ser-Val |
| Mage-1 (161-169),
human |
TYM005-010 |
Glu-Ala-Asp-Pro-Thr-Gly-His-Ser-Tyr |
Melanoma Associated
Antigen 3 (167-176) [MAGE-3 Antigen
(167-176)], human |
TYM019-010 |
Met-Glu-Val-Asp-Pro-Ile-Gly-His-Leu-Tyr |
| Ser-Tyr-Leu-Gln-Asp-Ser-Val-Pro-Asp-Ser-Phe-Gln-Asp |
TYS017-010 |
Ser-Tyr-Leu-Gln-Asp-Ser-Val-Pro-Asp-Ser-Phe-Gln-Asp |
| Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp |
TYT015-010 |
Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp |
| [MAGE-3 Antigen
(271-279)], human |
TYM006-010 |
Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val |
|
|
| ·Neuromedins |
Product |
CAT# |
Sequence |
Neurokinin
A (4-10) |
TYN015-010 |
Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 |
Neurokinin
A / Substance K |
TYN016-010 |
His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 |
Neurokinin
B |
TYN017-005
TYN017-010 |
Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 |
Neuromedin
(U-25), porcine |
TYN018-005
TYN018-010 |
Phe-Lys-Val-Asp-Glu-Glu-Phe-Gln-Gly-Pro-Ile-Val-Ser-Gln-Asn-Arg-Arg-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
Neuromedin
(U-8), porcine |
TYN019-010 |
Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
Neuromedin
B |
TYN020-010 |
Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2 |
Neuromedin
C |
TYN021-010 |
Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
Neuromedin
U, rat |
TYN023-005
TYN023-010 |
Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 |
[Tyr0]
Neurokinin B |
TYN026-005 |
Tyr-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 |
|
|
| ·Neurotensin |
Product |
CAT# |
Sequence |
Neurotensin
(8-13) |
TYN032-010 |
Arg-Arg-Pro-Tyr-Ile-Leu |
Neurotensin
(8-13), N-Acetyl |
TYN033-010 |
Ac-Arg-Arg-Pro-Tyr-Ile-Leu |
[Lys8,Asn9]
Neurotensin LANT-6 (8-13) |
TYN037-010 |
Lys-Asn-Pro-Tyr-Ile-Leu |
[Trp11]
Neurotensin (8-13) |
TYN038-010 |
Arg-Arg-Pro-Trp-Ile-Leu |
|
|
| |
